Potassium Chloride Extended-release Tablet, Extended Release
Product Images NDC 70010-135

5 FDA label images from Granules Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Potassium Chloride Extended-release (NDC 70010-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kcl-er-10meq-1000label-jpg (Kcl Er 10meq 1000label Jpg)

Kcl-er-10meq-1000label-jpg (Kcl Er 10meq 1000label Jpg)
Label for Potassium Chloride Extended-Release Tablets USP, 750 mg strength equivalent to 10 mEq potassium. The oral extended-release tablet is prescription only, packaged in a count of 1000 tablets. Manufactured by Granules India Limited and for Granules Pharmaceuticals Inc.*
FDA Label Image

Kcl-er-10meq-100label-jpg (Kcl Er 10meq 100label Jpg)

Kcl-er-10meq-100label-jpg (Kcl Er 10meq 100label Jpg)
Label for Potassium Chloride Extended-Release Tablets, USP, 10 mEq K strength. The label indicates the product contains 100 tablets, manufactured by Granules Pharmaceuticals Inc. in Chantilly, VA, with additional manufacturing by Granules India Limited in Hyderabad, India. The label includes dosage form as extended-release tablets, storage instructions, and a barcode with an NDC number.*
FDA Label Image

Kcl-er-10meq-500label-jpg (Kcl Er 10meq 500label Jpg)

Kcl-er-10meq-500label-jpg (Kcl Er 10meq 500label Jpg)
Potassium Chloride Extended-Release Tablets USP label for 10 mEq K strength, containing 500 tablets. The label lists a dosage form of extended-release tablets, with potassium chloride USP 750 mg per tablet. It includes storage instructions, a barcode, and manufacturer information: Granules Pharmaceuticals Inc., Chantilly, VA, with Granules India Limited, Hyderabad, India also referenced.*
FDA Label Image

Kcl-er-20meq-100label-jpg (Kcl Er 20meq 100label Jpg)

Kcl-er-20meq-100label-jpg (Kcl Er 20meq 100label Jpg)
Label for Potassium Chloride Extended-Release Tablets, USP, 20 mEq strength, containing 100 tablets. The label identifies the product as an oral extended-release tablet by Granules Pharmaceuticals Inc., with packaging details including storage instructions, dosage information, and manufacturing origin (India). A barcode and NDC number (70010-135-01) are also present.*
FDA Label Image

Kcl-er-20meq-500label-jpg (Kcl Er 20meq 500label Jpg)

Kcl-er-20meq-500label-jpg (Kcl Er 20meq 500label Jpg)
Potassium Chloride Extended-Release Tablets, USP label showing 20 mEq strength in red highlight, quantity of 500 tablets, oral extended-release tablets by Granules Pharmaceuticals Inc. The label includes storage instructions, dosage notes, and manufacturer details with a barcode visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.